Prelude Therapeutics Inc 10-Q for FY2022 Q2
Prelude Therapeutics Inc (PRLD)
10-Q
2022-08-09
For: 2022-06-30
View Original
Added on
April 06, 2026
About this 10-Q
Prelude Therapeutics Inc filed this 10-Q on August 9, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $27.37M
- compared with a net loss of $26.87M a year earlier
- Diluted EPS
- -$0.58
- compared with -$0.58 a year earlier